Discovery and development of CP-724714, a selective HER2 receptor tyrosine kinase inhibitor
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. Jani, E. Barbacci, S. Bhattacharya, C. Boos, M. Campbell, T. Clark, K. Coleman, R. Connell, T. Cosker
Institution: Pfizer (United States)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2525012249